FRMPD4, a causal gene for intellectual disability and epilepsy, is associated with X-linked non-syndromic hearing loss

This study identifies FRMPD4 as a causal gene for X-linked non-syndromic sensorineural hearing loss, expanding its known phenotypic spectrum beyond intellectual disability and epilepsy through genetic analysis of affected families and functional validation across Drosophila, zebrafish, and mouse models.

The Gist

The "Sound Switch" That Was Found in the Wrong Place

Imagine your body is a massive, high-tech city. In this city, there are specialized construction crews responsible for building different neighborhoods: one crew builds the brain's "thinking towers," another builds the "balance towers," and a third builds the "hearing towers."

For a long time, scientists knew about a specific construction foreman named FRMPD4. They thought this foreman only worked on the Thinking Towers. When the foreman's instructions were messed up (due to a genetic typo), the thinking towers would get damaged, leading to intellectual disabilities or seizures (epilepsy).

But in this new study, scientists discovered something surprising: FRMPD4 is actually a multi-talented foreman who also oversees the construction of the Hearing Towers.

Here is the story of how they found out, explained simply:

1. The Mystery of the Two Families

The story starts with two families who had a very specific problem: their sons were born deaf, but they were otherwise perfectly healthy. They could think, learn, and move just fine. They didn't have the intellectual disabilities usually linked to the "FRMPD4" gene.

Scientists acted like genetic detectives. They scanned the families' DNA, looking for the "typo" that caused the deafness. They found it! Both families had a tiny mistake in the FRMPD4 gene.

• The Twist: This gene is located on the X chromosome (which men only have one of, making them more vulnerable to X-linked issues).
• The Discovery: The mistake wasn't in the part of the gene that builds the brain; it was in a different section, the "tail" of the protein. This explained why these boys had hearing loss but no brain issues. It was like a typo in the blueprint for the "hearing door" that didn't affect the "thinking room."

2. The Animal Detective Work

To prove that this gene really controls hearing, the scientists didn't just look at humans; they went on a field trip to the animal kingdom. They used three different "test subjects" to see if the rule applied everywhere.

• The Fruit Fly (The Tiny Ear):
  Fruit flies have tiny ears on their antennae. The scientists found the fly version of FRMPD4 (which they nicknamed ngh, short for the German phrase "nicht gut hörend," meaning "not hearing well").

  • The Experiment: They turned off the gene in the flies.
  • The Result: The flies' antennae stopped vibrating properly. It was like taking the springs out of a microphone; the sound waves hit the antenna, but the antenna couldn't bounce back to send the signal to the brain. The flies were effectively deaf.

• The Zebrafish (The Underwater Microphone):
  Zebrafish have tiny hair cells in their ears and along their sides (the lateral line) that sense water vibrations.

  • The Experiment: The scientists broke the gene in baby fish.
  • The Result: The fish didn't just have fewer hair cells; the cells that were there were malformed, like a house built with crooked bricks. When a loud noise was made, the mutant fish didn't jump (the "startle response") like normal fish did. They were too slow to react, as if they didn't hear the danger coming.

• The Mouse (The High-Frequency Test):
  Mice are the closest relatives to humans. The scientists used mice where the FRMPD4 gene was completely deleted.

  • The Result: These mice were healthy and smart, but they couldn't hear high-pitched sounds (like a dog whistle). Their inner ears looked slightly damaged, similar to what is seen in the human families.

3. The Big Picture: A New Map for Doctors

Why does this matter?

Think of the FRMPD4 gene as a Swiss Army Knife.

• Before this study, doctors thought the knife only had a screwdriver (for the brain).
• Now, they realize it also has a corkscrew (for the ears).

Depending on where the break happens on the gene:

• If the break is in the "screwdriver" part, you get brain issues.
• If the break is in the "corkscrew" part (like in these two families), you get hearing loss but a healthy brain.

The Takeaway

This paper is a "eureka!" moment for genetic medicine. It tells doctors: "If you see a patient with unexplained hearing loss, especially in boys, check the FRMPD4 gene!"

It also shows us that evolution is efficient. The same tool (the gene) is used to build different parts of the body in humans, flies, fish, and mice. By understanding how this tool works in a tiny fly or a fish, we can finally solve the mystery of human deafness and give families a clear answer about what is happening in their DNA.

Technical Summary

1. Problem Statement

• Genetic Heterogeneity: Hereditary non-syndromic hearing loss (NSHL) is highly genetically heterogeneous. While over 155 genes are associated with NSHL, X-linked forms are rare (2–5% of cases) and only five genes (AIFM1, POU3F4, COL4A6, PRPS1, SMPX) were previously known.
• Phenotypic Expansion: Many genes associated with neurodevelopmental disorders (e.g., intellectual disability, epilepsy) also contribute to isolated auditory phenotypes (pleiotropy). However, the specific role of FRMPD4 (FERM and PDZ Domain Containing 4) in hearing had not been explored.
• Clinical Gap: FRMPD4 was previously linked to X-linked intellectual disability (ID), epilepsy, and schizophrenia, but its potential causality in non-syndromic hearing loss remained uncharacterized, creating a diagnostic gap for patients presenting with hearing loss but lacking other neurodevelopmental features.

2. Methodology

The study employed a multi-modal approach combining human genetics, clinical phenotyping, and cross-species functional validation.

• Human Genetics & Clinical Assessment:

  • Cohort: Two unrelated families (Family 1: European; Family 2: Middle Eastern) with non-syndromic sensorineural hearing loss (NSHL).
  • Sequencing: Exome sequencing (WES) was performed on affected individuals and parents. Variants were filtered against databases (gnomAD, TopMed, All of Us) and prioritized based on inheritance patterns (X-linked, autosomal).
  • Clinical Phenotyping: Detailed audiological assessments (pure-tone audiometry, OAEs, ABR, speech discrimination) and neurological evaluations were conducted to confirm the absence of syndromic features (ID, epilepsy).

• Cross-Species Functional Models:

  • Drosophila melanogaster: Used the ngh (nicht gut hörend) ortholog of FRMPD4.
    • Generated a CRISPR/Cas9 knockout (KO) line.
    • Assessed expression via reporter lines (Gal4/UAS) in Johnston's Organ Neurons (JONs).
    • Measured mechanical free fluctuations of the antennal sound receiver and sound-evoked Compound Action Potentials (CAPs) to quantify hearing function.
  • Zebrafish (Danio rerio): Used frmpd4 loss-of-function models (ENU mutant sa12377, Morpholino knockdown, and CRISPR/Cas9).
    • Analyzed expression via whole-mount in situ hybridization.
    • Quantified neuromast development in the otic vesicle (OV) and posterior lateral line (PLL) using DASPEI staining and scanning electron microscopy (SEM).
    • Assessed neuronal development via acetylated tubulin immunofluorescence.
    • Tested behavioral hearing capacity via acoustic startle response assays.
  • Mouse (Mus musculus): Used conditional Frmpd4 knockout (KO) mice (originally Preso1 KO).
    • Performed qPCR and immunofluorescence to map expression in the cochlea (organ of Corti, spiral ganglion).
    • Conducted Auditory Brainstem Response (ABR) testing to measure hearing thresholds across frequencies.
    • Analyzed cochlear morphology via confocal microscopy (Phalloidin/TUBB3 staining).

3. Key Contributions

• Novel Gene Discovery: Identified FRMPD4 as a novel X-linked gene for non-syndromic sensorineural hearing loss.
• Phenotypic Expansion: Demonstrated that FRMPD4 variants can cause isolated hearing loss without the intellectual disability or epilepsy typically associated with other FRMPD4 mutations.
• Evolutionary Conservation: Provided robust evidence that FRMPD4 function in auditory pathways is evolutionarily conserved across invertebrates (flies), fish, and mammals.
• Genotype-Phenotype Correlation: Suggested that missense variants in the C-terminal region (specifically affecting protein-protein interaction motifs) may lead to isolated hearing loss, whereas truncating variants or N-terminal deletions are associated with severe neurodevelopmental phenotypes.

4. Results

• Human Genetic Findings:

  • Family 1: Identified a hemizygous missense variant c.3755C>T (p.Ser1252Phe) in FRMPD4. Affected males presented with mild-to-moderate, prelingual, bilateral NSHL. No ID or epilepsy was observed.
  • Family 2: Identified a hemizygous missense variant c.2425G>A (p.Ala809Thr) in FRMPD4. The proband had severe congenital NSHL.
  • Variant Analysis: Both variants are absent in major population databases, highly conserved across vertebrates, and predicted to be deleterious. They map to the C-terminal region, near the HOMER ligand-binding motif and PDZ-binding motif, but do not disrupt the N-terminal PDZ or FERM domains.

• Drosophila Results:

  • ngh (the fly ortholog) is expressed in Johnston's Organ Neurons (JONs).
  • ngh KO flies exhibited reduced mechanical amplification (compressive nonlinearity) and lower CAP amplitudes, indicating impaired JON motility and active hearing mechanisms.

• Zebrafish Results:

  • frmpd4 is expressed in the otic vesicle and lateral line primordium during development.
  • Loss of function resulted in a significant reduction of neuromast clusters in the posterior lateral line and otic vesicle, increased distance between clusters, and disrupted axonal projections.
  • SEM revealed collapsed epidermal openings and reduced kinocilia in mutants.
  • Adult mutants showed significantly reduced and delayed acoustic startle responses, confirming hearing impairment.

• Mouse Results:

  • Frmpd4 is expressed in spiral ganglion neurons (SGNs) and the organ of Corti.
  • Frmpd4 KO mice displayed morphological alterations in the cochlear epithelium (hair cells) but normal neuronal development markers (TUBB3).
  • ABR Testing: KO mice exhibited significant high-frequency hearing loss (elevated thresholds at 24 and 32 kHz) compared to wild-type littermates, recapitulating the human phenotype.

5. Significance

• Clinical Impact: This study expands the diagnostic panel for X-linked non-syndromic hearing loss. Clinicians should consider FRMPD4 in patients with NSHL, even in the absence of ID or epilepsy.
• Diagnostic Precision: The findings highlight the importance of distinguishing between variant types (missense vs. truncating) and locations (C-terminal vs. N-terminal) to predict phenotypic outcomes (isolated hearing loss vs. syndromic neurodevelopmental disorders).
• Mechanistic Insight: The data suggests that FRMPD4 plays a critical, conserved role in the development and function of auditory sensory cells (hair cells and neurons) across species. The interaction of the C-terminal domain with partners like HOMER proteins or the LGN/GPSM2 complex appears crucial for auditory function, while the N-terminal domain may be more critical for dendritic spine morphogenesis and cognitive function.
• Therapeutic Implications: Understanding the specific molecular pathways disrupted by these variants (e.g., protein scaffolding in the synapse) opens new avenues for targeted therapies for hearing loss.

In conclusion, the paper establishes FRMPD4 as a critical gene for auditory function, bridging the gap between neurodevelopmental genetics and sensory biology through rigorous cross-species validation.